Filing Flows › TherapeuticsMD (TXMD) › Q1 2026 › vs Q4 2025
TherapeuticsMD (TXMD) Q1 2026 vs Q4 2025 (quarter over quarter)
TherapeuticsMD's revenue fell $169K (-19%) from $893K in Q4 2025 to $724K in Q1 2026.
TherapeuticsMD, Q1 2026: revenue $724K (+84% year over year), operating margin -99.9%, net earnings $95K, operating cash flow $944K. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $724K | $893K | −$169K | -19% |
| Other income, net | $826K | $972K | −$146K | -15% |
| Costs & expenses | $1.6M | $2.5M | −$934K | -38% |
| Operating costs | $1.4M | $2.4M | −$998K | -41% |
| Income tax | $8K | $39K | −$31K | -79% |
| Net earnings | $95K | −$619K | $714K | — |
| General & admin | $1.4M | $2.3M | −$939K | -41% |
| Other operating costs | $94K | $153K | −$59K | -39% |
| Operating cash sources | $944K | $375K | $569K | +152% |
| Depreciation & amortization | $94K | $97K | −$3K | -3% |
| Share-based compensation | $2K | $51K | −$49K | -96% |
| Working capital & other | $753K | $846K | −$93K | -11% |
| Operating cash flow | $944K | $375K | $569K | +152% |
Questions
How much did TherapeuticsMD's revenue grow quarter over quarter in Q1 2026?
TherapeuticsMD's revenue fell $169K (-19%) from $893K in Q4 2025 to $724K in Q1 2026.